Optimal computerized management of developments for pharmaceutical companies

The choice of the optimal project for product development until the registration, is fundamental for best management results (better, faster and cheaper) of the various departments in a pharmaceutical company. The methodology of decision analysis rationale presented in this work is based upon data to estimate the probability of realizing projects. This is done by comparing the real versus the anticipated project by using schedule-plans during the process. This method is illustrated by describing computerized systems to manage tasks in a clinical development with GANTT diagrams and PERT networks. These computerized systems enable to estimate the full duration of a project and help to determine the critical path to take. In this example, the project presented can correspond to the full development of drugs or medical devices, from the preclinical phases through the registration without forgetting phase 4 (post-marketing phase).